日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities

靶向治疗相关的心脏毒性在伴或不伴心脏合并症的IV期肺癌患者中的表现

Peng, Yanmei; Li, Dong; Wampfler, Jason A; Luo, Yung-Hung; Kumar, Ashok V; Gu, Zhong; Kosuru, Nikhila; Yu, Nathan Y; Wang, Zhichao; Leventakos, Konstantinos; Ernani, Vinicius; Yang, Ping

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab、Tremelimumab 和铂类化疗治疗 EGFR 突变阳性非小细胞肺癌:一项开放标签 2 期试验 (ILLUMINATE)

Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony J; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G M; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M; Stockler, Martin R; Solomon, Benjamin J; John, Thomas; Chih-Hsin Yang, James

A Prospective Exploratory Study of Functional Immunity Assessed by Pretreatment Interferon Gamma Release Assay in Relation to Different Systemic Therapies in Patients With Advanced-Stage NSCLC

一项前瞻性探索性研究,旨在评估晚期非小细胞肺癌患者接受不同全身治疗后,通过治疗前干扰素γ释放试验评估的功能性免疫之间的关系

Huang, Hsu-Ching; Chang, Han-Jhih; Chiang, Chi-Lu; Huang, Hsin-Yi; Luo, Yung-Hung; Chen, Yuh-Min; Shiao, Tsu-Hui; Chiu, Chao-Hua

The role of immunotherapy and chemotherapy combinations in TKI-resistant EGFR-mutant non-small cell lung cancer: insights from real-world evidence

免疫疗法和化疗联合治疗在TKI耐药的EGFR突变型非小细胞肺癌中的作用:来自真实世界证据的启示

Chen, I-Ting; Huang, Hsu-Ching; Chiang, Chi-Lu; Shen, Chia-I; Tseng, Yen-Han; Liao, Ying-Ting; Chen, Yuh-Min; Luo, Yung-Hung

BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases

在患有EGFR突变型肺腺癌和脑转移的亚洲患者中,BBB穿透性酪氨酸激酶抑制剂联合颅内放射治疗与单独使用BBB穿透性TKI的疗效比较

Chen, You-Cong; Lin, Chun-Fu; Chiang, Chi-Lu; Yang, Huai-Che; Wu, Hsiu-Mei; Chen, Ching-Jen; Luo, Yung-Hung; Hu, Yong-Sin; Lin, Chung-Jung; Chung, Wen-Yuh; Shiau, Cheng-Ying; Guo, Wan-Yuo; Pan, David Hung-Chi; Lee, Cheng-Chia

Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancer

晚期 HER2 突变型非小细胞肺癌的真实世界治疗策略和生存结果

Sun, Ruei-Lin; Liao, Pei-Ya; Liao, Ying-Ting; Yeh, Yi-Chen; Chiang, Chi-Lu; Chen, Yuh-Min; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Huang, Yen-Hsiang; Luo, Yung-Hung; Yang, Tsung-Ying

First-line immune checkpoint inhibitors plus chemotherapy in Taiwanese patients with extensive-stage small-cell lung cancer

一线免疫检查点抑制剂联合化疗治疗台湾广泛期小细胞肺癌患者

Liao, Ying-Ting; Sun, Ruei-Lin; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Luo, Yung-Hung; Chen, Yuh-Min; Chiang, Chi-Lu

TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy

TCCIA:探索环状RNA在癌症免疫治疗中的应用的综合资源

Wang, Shixiang; Xiong, Yi; Zhang, Yihao; Wang, Haitao; Chen, Minjun; Li, Jianfeng; Luo, Peng; Luo, Yung-Hung; Hecht, Markus; Frey, Benjamin; Gaipl, Udo; Li, Xuejun; Zhao, Qi; Ma, Hu; Zhou, Jian-Guo

Immune signatures of patients with advanced non-small-cell lung cancer for efficacy prediction after immunotherapy.

晚期非小细胞肺癌患者的免疫特征用于预测免疫治疗后的疗效

Luo Yung-Hung, Shen Chia-I, Chiang Chi-Lu, Chen Yuh-Min

Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521

利用全基因组测序技术对台湾非小细胞肺癌基因改变进行登记:一项真实世界队列研究——台湾肿瘤协作组 T1521

Liao, Bin-Chi; Chiang, Nai-Jung; Chang, Gee-Chen; Su, Wu-Chou; Luo, Yung-Hung; Chong, Inn-Wen; Yang, Tsung-Ying; Lai, Chun-Liang; Hsia, Te-Chun; Ho, Ching-Liang; Lee, Kang-Yun; Hsiao, Chin-Fu; Ku, Fan-Chen; Fang, Wei-Tse; Chih-Hsin Yang, James